• Something wrong with this record ?

Three Is a Magic Number: Tailored Clickable Chelators Used to Determine Optimal RGD-Peptide Multiplicity in αvβ6-Integrin Targeted 177Lu-Labeled Cancer Theranostics

T. Rheinfrank, V. Lebruška, S. Stangl, M. Vojtíčková, NT. Nguyen, L. Koller, J. Šimeček, V. Kubíček, S. Kossatz, J. Notni

. 2024 ; 35 (12) : 1970-1984. [pub] 20241128

Language English Country United States

Document type Journal Article

The cellular adhesion receptor αvβ6-integrin is highly expressed in many cancers, e.g., pancreatic, lung, head-and-neck, cervical, bladder, and esophageal carcinoma. Multimerization of αvβ6-integrin-specific RGD peptides increases the target affinity and retention but affects biodistribution and pharmacokinetics. Amide formation of the terminal carboxylic acid moieties of the square-symmetrical bifunctional chelator DOTPI with 3-azidopropylamine yields derivatives with 4, 3, and 2 terminal azides and zero, 1, and 2 remaining carboxylic acids, respectively, whereby formation of the 2-cis-isomer is preferred according to NMR investigation of the Eu(III)-complexes. Cu(II)-catalyzed alkyne-azide cycloaddition (CuAAC) of the alkyne-functionalized αvβ6-integrin binding peptide cyclo[YRGDLAYp(NMe)K(pent-4-ynoic amide)] (Tyr2) yields the respective di-, tri-, and tetrameric conjugates for Lu-177-labeling. In mice bearing αvβ6-integrin-expressing xenografts of H2009 (human lung adenocarcinoma) cells, the Lu-177-labeled trimer's tumor-to-blood ratio of 112 exceeds that of the tetramer (10.4) and the dimer (54). Co-infusion of gelofusine (succinylated gelatin) reduces the renal uptake of the trimer by 89%, resulting in a 10-fold better tumor-to-kidney ratio, while no improvement of that ratio is observed with arginine/lysine, para-aminohippuric acid (PAH), and hydroxyethyl starch (HES) coinfusions. Since the Lu-177-labeled Tyr2-trimer outperforms the dimer and the tetramer, such trimers are considered the best lead structures for the ongoing development of αvβ6-integrin targeted anticancer theranostics.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25003017
003      
CZ-PrNML
005      
20250206104016.0
007      
ta
008      
250121s2024 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1021/acs.bioconjchem.4c00481 $2 doi
035    __
$a (PubMed)39608839
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Rheinfrank, Tim $u Department of Nuclear Medicine, TUM University Hospital and Central Institute for Translational Cancer Research, (TranslaTUM), School of Medicine, Technical University Munich, 81675 Munich, Germany
245    10
$a Three Is a Magic Number: Tailored Clickable Chelators Used to Determine Optimal RGD-Peptide Multiplicity in αvβ6-Integrin Targeted 177Lu-Labeled Cancer Theranostics / $c T. Rheinfrank, V. Lebruška, S. Stangl, M. Vojtíčková, NT. Nguyen, L. Koller, J. Šimeček, V. Kubíček, S. Kossatz, J. Notni
520    9_
$a The cellular adhesion receptor αvβ6-integrin is highly expressed in many cancers, e.g., pancreatic, lung, head-and-neck, cervical, bladder, and esophageal carcinoma. Multimerization of αvβ6-integrin-specific RGD peptides increases the target affinity and retention but affects biodistribution and pharmacokinetics. Amide formation of the terminal carboxylic acid moieties of the square-symmetrical bifunctional chelator DOTPI with 3-azidopropylamine yields derivatives with 4, 3, and 2 terminal azides and zero, 1, and 2 remaining carboxylic acids, respectively, whereby formation of the 2-cis-isomer is preferred according to NMR investigation of the Eu(III)-complexes. Cu(II)-catalyzed alkyne-azide cycloaddition (CuAAC) of the alkyne-functionalized αvβ6-integrin binding peptide cyclo[YRGDLAYp(NMe)K(pent-4-ynoic amide)] (Tyr2) yields the respective di-, tri-, and tetrameric conjugates for Lu-177-labeling. In mice bearing αvβ6-integrin-expressing xenografts of H2009 (human lung adenocarcinoma) cells, the Lu-177-labeled trimer's tumor-to-blood ratio of 112 exceeds that of the tetramer (10.4) and the dimer (54). Co-infusion of gelofusine (succinylated gelatin) reduces the renal uptake of the trimer by 89%, resulting in a 10-fold better tumor-to-kidney ratio, while no improvement of that ratio is observed with arginine/lysine, para-aminohippuric acid (PAH), and hydroxyethyl starch (HES) coinfusions. Since the Lu-177-labeled Tyr2-trimer outperforms the dimer and the tetramer, such trimers are considered the best lead structures for the ongoing development of αvβ6-integrin targeted anticancer theranostics.
650    _2
$a zvířata $7 D000818
650    12
$a integriny $x metabolismus $7 D016023
650    _2
$a lidé $7 D006801
650    12
$a oligopeptidy $x chemie $x farmakokinetika $7 D009842
650    _2
$a myši $7 D051379
650    12
$a chelátory $x chemie $7 D002614
650    12
$a lutecium $x chemie $7 D008187
650    12
$a radionuklidy $x chemie $7 D011868
650    12
$a antigeny nádorové $x metabolismus $7 D000951
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a tkáňová distribuce $7 D014018
650    _2
$a click chemie $7 D057930
650    _2
$a nádory $x farmakoterapie $7 D009369
650    _2
$a radiofarmaka $x farmakokinetika $x chemie $x terapeutické užití $7 D019275
650    _2
$a myši nahé $7 D008819
650    _2
$a teranostická nanomedicína $x metody $7 D000068936
655    _2
$a časopisecké články $7 D016428
700    1_
$a Lebruška, Viktor $u Department of Inorganic Chemistry, Faculty of Science, Charles University, Hlavova 8, 128 42 Prague 2, Czech Republic
700    1_
$a Stangl, Stefan $u Department of Nuclear Medicine, TUM University Hospital and Central Institute for Translational Cancer Research, (TranslaTUM), School of Medicine, Technical University Munich, 81675 Munich, Germany
700    1_
$a Vojtíčková, Margareta $u Department of Inorganic Chemistry, Faculty of Science, Charles University, Hlavova 8, 128 42 Prague 2, Czech Republic
700    1_
$a Nguyen, Nghia Trong $u Department of Nuclear Medicine, TUM University Hospital and Central Institute for Translational Cancer Research, (TranslaTUM), School of Medicine, Technical University Munich, 81675 Munich, Germany
700    1_
$a Koller, Lena $u Department of Nuclear Medicine, TUM University Hospital and Central Institute for Translational Cancer Research, (TranslaTUM), School of Medicine, Technical University Munich, 81675 Munich, Germany
700    1_
$a Šimeček, Jakub $u TRIMT GmbH, Carl-Eschebach-Str. 7, 01454 Radeberg, Germany
700    1_
$a Kubíček, Vojtěch $u Department of Inorganic Chemistry, Faculty of Science, Charles University, Hlavova 8, 128 42 Prague 2, Czech Republic $1 https://orcid.org/0000000301715713 $7 uk2007350367
700    1_
$a Kossatz, Susanne $u Department of Nuclear Medicine, TUM University Hospital and Central Institute for Translational Cancer Research, (TranslaTUM), School of Medicine, Technical University Munich, 81675 Munich, Germany
700    1_
$a Notni, Johannes $u TRIMT GmbH, Carl-Eschebach-Str. 7, 01454 Radeberg, Germany $u Institute of Pathology, School of Medicine, Technical University Munich, Trogerstr. 18, D-81675 München, Germany $1 https://orcid.org/0000000239643391
773    0_
$w MED00006454 $t Bioconjugate chemistry $x 1520-4812 $g Roč. 35, č. 12 (2024), s. 1970-1984
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39608839 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206104011 $b ABA008
999    __
$a ok $b bmc $g 2263043 $s 1239024
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 35 $c 12 $d 1970-1984 $e 20241128 $i 1520-4812 $m Bioconjugate chemistry $n Bioconjug Chem $x MED00006454
LZP    __
$a Pubmed-20250121

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...